Kylhammar David, Bune Laurids T, Rådegran Göran
The Öresund Cardiovascular Research Collaboration, The Section for Heart Failure and Valvular Disease, The Clinic for Heart- and Lung Disease, Skåne University Hospital, 221 85, Lund, Sweden,
Eur J Appl Physiol. 2014 Sep;114(9):1995-2006. doi: 10.1007/s00421-014-2921-y. Epub 2014 Jun 15.
To investigate the role of P2Y₁ and P2Y₁₂ receptors in hypoxia- and adenosine diphosphate (ADP)-induced pulmonary vasoconstriction.
19 anaesthetized, mechanically ventilated pigs (31.3 ± 0.7 kg) were evaluated in normoxia and hypoxia, without (n = 6) or with P2Y₁ receptor antagonist MRS2500 (n = 7) or P2Y₁₂ receptor antagonist cangrelor (n = 6) treatment. 12 pigs (29.3 ± 0.4 kg) were evaluated before and during ADP infusion, without and with MRS2500 (n = 6) or cangrelor (n = 6) pre-treatment.
Hypoxia increased (p < 0.05) mean pulmonary artery pressure (MPAP) by 14.2 ± 1.1 mmHg and pulmonary vascular resistance (PVR) by 2.7 ± 0.4 WU. Without treatment MPAP and PVR remained unaltered (p = ns) for 90 min hypoxia. During hypoxia MRS2500 decreased (p < 0.013) MPAP by 4.3 ± 1.2 mmHg within 15 min. Cangrelor decreased (p < 0.036) MPAP to be 3.3 ± 0.4 and 3.6 ± 0.6 mmHg lower than hypoxia baseline after 10 and 30 min. PVR was, however, unaltered (p = ns) by MRS2500 or cangrelor during hypoxia. ADP increased (p < 0.001) MPAP and PVR to stabilize 11.1 ± 1.3 mmHg and 2.7 ± 0.3 WU higher than baseline. MRS2500 or cangrelor pre-treatment totally abolished the sustained MPAP- and PVR-increases to ADP.
ADP elicits pulmonary vasoconstriction through P2Y₁ and P2Y₁₂ receptor activation. ADP is not a mandatory modulator, but may still contribute to pulmonary vascular tone during acute hypoxia. Further investigations into the mechanisms behind ADP-induced pulmonary vasoconstriction and the role of ADP as a modulator of pulmonary vascular tone during hypoxia are warranted.
研究P2Y₁和P2Y₁₂受体在缺氧和二磷酸腺苷(ADP)诱导的肺血管收缩中的作用。
对19只麻醉、机械通气的猪(31.3±0.7千克)在常氧和缺氧状态下进行评估,其中6只未接受治疗,7只接受P2Y₁受体拮抗剂MRS2500治疗,6只接受P2Y₁₂受体拮抗剂坎格雷洛治疗。对12只猪(29.3±0.4千克)在输注ADP前及输注过程中进行评估,其中6只未接受预处理,6只接受MRS2500或坎格雷洛预处理。
缺氧使平均肺动脉压(MPAP)升高(p<0.05)14.2±1.1毫米汞柱,肺血管阻力(PVR)升高2.7±0.4伍德单位。未经治疗时,90分钟缺氧期间MPAP和PVR保持不变(p=无统计学意义)。缺氧期间,MRS2500在15分钟内使MPAP降低(p<0.013)4.3±1.2毫米汞柱。坎格雷洛在10分钟和30分钟后使MPAP分别比缺氧基线降低3.3±0.4和3.6±0.6毫米汞柱(p<0.036)。然而,缺氧期间MRS2500或坎格雷洛对PVR无影响(p=无统计学意义)。ADP使MPAP和PVR升高(p<0.001),稳定在比基线高11.1±1.3毫米汞柱和2.7±0.3伍德单位。MRS2500或坎格雷洛预处理完全消除了ADP引起的MPAP和PVR持续升高。
ADP通过激活P2Y₁和P2Y₁₂受体引发肺血管收缩。ADP不是必需的调节因子,但在急性缺氧期间仍可能对肺血管张力有影响。有必要进一步研究ADP诱导肺血管收缩的机制以及ADP在缺氧期间作为肺血管张力调节因子的作用。